Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Filings indexed 1,179 across all filing types
Latest filing 2020-08-04 Report Publication Anno…
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Uzupełnienie jednostkowego raportu rocznego Spółki za 2019 - Content (PL)
Report Publication Announcement Classification · 98% confidence The document is a current report (raport bieżący) from Selvita S.A. announcing an amendment/supplement (uzupełnienie) to its 2019 annual report (jednostkowego raportu rocznego Spółki za rok 2019). Specifically, it adds an 'Additional Note' (Nota Dodatkowa) regarding R&D services revenue, driven by the company's application for 'Research and Development Center' (CBR) status. The text explicitly states that the fully updated annual report, which includes the re-audited financial statements, will be transmitted 'immediately after the publication of this current report' (niezwłocznie po publikacji niniejszego raportu bieżącego). According to Rule 2 ('MENU VS MEAL' Rule), a document announcing the publication of a report, especially when the full report is forthcoming, should be classified as a Report Publication Announcement (RPA). The document is short (1842 chars) and serves to inform the market about the upcoming release of the corrected 10-K/Annual Report.
2020-08-04 Polish
Otrzymanie kolejnego zlecenia w ramach umowy znaczącej - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a brief announcement from the Management Board (Zarząd) of Selvita S.A. regarding receiving a new, significant order (Zlecenie) from a European biotech company under an existing framework agreement. It details the value of the new order (523,789 EUR) and the cumulative value of the contract for 2020, noting that the contract value increased by 27% and is considered significant. This type of announcement, detailing a specific business contract or order that impacts the company's operations or financial outlook, fits best under the general category of Regulatory Filings (RNS) if a more specific category like M&A (TAR) or Capital Change (CAP) does not apply. Since it is not a formal financial report (10-K, IR, ER), nor a management change (MANG), nor a dividend notice (DIV), RNS serves as the appropriate classification for a material, non-standard regulatory disclosure.
2020-07-06 Polish
Dopuszczenie i wprowadzenie do obrotu giełdowego Akcji Serii C oraz wyznaczenie ostatniego dnia notowania PDA Serii C - Content (PL)
Regulatory Filings Classification · 95% confidence The document is very short (937 characters) and announces official actions regarding the admission and introduction of new shares ('Akcje Serii C') to trading on the Warsaw Stock Exchange (GPW). It specifically mentions resolutions from the GPW Board regarding the admission of shares and the final trading day for previous series (PDA Serii C). This content relates to capital structure changes and stock market listing procedures. While it is an announcement, it is not a general 'Report Publication Announcement' (RPA) but a specific regulatory event concerning the listing/trading of shares. This fits best under 'Share Issue/Capital Change' (SHA) as it details the formal steps for new shares to enter the market, or potentially 'Regulatory Filings' (RNS) if SHA is too specific for a listing notice. Given the focus on the admission and introduction of new shares to the main market, SHA is the most precise fit, as it covers capital structure changes related to issuance.
2020-06-24 Polish
Zawiadomienie_art. 69 OFertPublU_zał do RB 23/2020
Major Shareholding Notification Classification · 95% confidence The document is titled "ZAWIADOMIENIE O ZMIANIE STANU POSIADANIA" (Notification of Change in Holding) and explicitly references Polish law ("Ustawa o ofercie publicznej"). It details a change in the percentage of votes held by an individual (Paweł Przewięźlikowski) in Selvita S.A. following a capital increase. This type of filing, reporting changes in significant share ownership or insider transactions, aligns best with the definition of Major Shareholding Notification (MRQ) or Director's Dealing (DIRS). Since the notification is triggered by a capital change affecting the percentage held by an individual, and it details the exact number of shares and voting rights before and after the event, it strongly suggests a notification of a change in a major holding threshold. Given the context of reporting changes in ownership percentage, MRQ is the most appropriate classification, although DIRS could also apply if the individual is a director. However, the focus is on the change in the total holding percentage (from 42.41% to 37.90%), which is characteristic of major shareholding notifications.
2020-06-22 Polish
Otrzymanie zawiadomienia w trybie art. 69 OfertPublU w związku z rejestracją podwyższenia kapitału zakładowego Emitenta - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document text is very short (692 characters) and explicitly states that the company received a notification ('otrzymaniu zawiadomienia') from a significant shareholder and Board Member regarding a change in voting rights, which is being transmitted in an attachment ('które Spółka przekazuje w załączeniu do niniejszego raportu'). This structure—announcing the receipt/transmission of a regulatory notification rather than being the full notification itself—strongly suggests a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the content specifically relates to a change in shareholding/voting rights by an insider/major shareholder, it is closely related to DIRS or MRQ, but the document's primary function here is announcing the *receipt* of the filing. Given the short length and the focus on transmitting an attached document, RPA is the most appropriate classification based on Rule 2 (The 'MENU VS MEAL' Rule).
2020-06-22 Polish
Rejestracja podwyższenia kapitału zakładowego Spółki - Content (PL)
Share Issue/Capital Change Classification · 98% confidence The document text, written in Polish, explicitly states that the Management Board ('Zarząd') of Selvita S.A. is informing about the registration of an increase in the company's share capital ('podwyższenia kapitału zakładowego Spółki') by the National Court Register. It then details the new structure of the share capital, including the total amount and the breakdown by share series (A, B, C). This content directly relates to changes in the company's capital structure resulting from a public share issuance. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). It is not an earnings release, an annual report, or a director's dealing.
2020-06-18 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.